Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) Study
Frailty before liver transplantation (LT) is a critical determinant of outcomes after LT. While frailty often improves after LT, it persists-and even worsens-in some. The extent to which post-LT frailty impacts longer-term outcomes has not been characterized. Adults with cirrhosis who underwent LT between 2013-2023 from 9 centers with an ambulatory frailty assessment [by Liver Frailty Index (LFI)] 12 months (+/- 6 mo) post-LT were included. Kaplan-Meier methods were used to estimate post-LT survival beyond 1y post-LT. Associations between 1y post-LT frailty and subsequent mortality were assessed using Cox regression. Linear regression was used to explore the association between 1y post-LT frailty and health-related quality life (HrQOL) using the 36-Item Short Form Survey. Among 1097 LT recipients, 144 (13%) patients were frail 1y post-LT. Those who were frail 1y post-LT were more often women (47% vs 33%), had MASLD (40% vs 19%), diabetes (44% vs 30%), stroke (3.5% vs 0.6%), and pre-LT frailty (37% vs. 16%) (all p≤0.001). At 3, 5, and 7 years after the 1y post-LT assessment, mortality was higher among those who were frail vs. not frail 1y post-LT (13% vs 6%, 24% vs 10%, and 32% vs 16%). After multivariate adjustment, 1y post-LT frailty was associated 2.0 times increased risk of post-LT mortality (95%CI 1.2-3.4, p=0.01) and worse physical HrQOL (Estimate -9.99, 95%CI -12.5 to -7.5, p<0.001). Patients who were frail 1y after LT experienced >2-fold increased risk of long-term mortality and poorer physical HrQOL. Patients who transitioned from not frail pre-LT to frail 1y post-LT had a 2.5-fold increased risk of post-LT mortality (95%CI 1.3-4.8, p=0.005) compared to patients who remained not frail. These findings suggest the 1y period after LT may be a critical window for evaluating whether targeted frailty-mitigation strategies may improving long-term survival among LT recipients.
Authors
- Elizabeth C. Verna (ORCID: https://orcid.org/0000-0002-9658-3751)
- Melinda Wang (ORCID: https://orcid.org/0000-0003-3440-6343)
- Amy M. Shui (ORCID: https://orcid.org/0000-0002-8243-6910)
- Jennifer C. Lai
- Daniel Ganger
- Matthew R. Kappus
- Robert Rahimi
- Meredith Pearson
- Marwan Ghabril (ORCID: https://orcid.org/0000-0002-4784-3246)
- Daniela P. Ladner (ORCID: https://orcid.org/0000-0001-5526-8272)
- Elizabeth A. King
- Andres Duarte-Rojo
Institutions
- Northwestern University (US)
- Johns Hopkins University (US)
- Duke University (US)
- University of California, San Francisco (US)
- University of Washington (US)
- Columbia University Irving Medical Center (US)
- Johns Hopkins Medicine (US)
- Baylor University Medical Center (US)
- Baylor Scott & White Health (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Liver Transplantation
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1097/lvt.0000000000000910
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 0.00